Eiko Lifescience
BSE: EIKO · Specialty Chemicals
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Unlock Eiko Lifescience's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Eiko Lifescience Limited is an Indian specialty chemicals company focused on the manufacturing and export of pharmaceutical intermediates, additives, and functional ingredients. The company serves diverse sectors including pharmaceuticals, agrochemicals, and personal care through a research-driven approach.
Business Model
The company generates revenue by manufacturing and supplying niche chemical molecules and intermediates to global and domestic clients. It leverages strategic collaborations and R&D capabilities to maintain its position within the life sciences supply chain.
Management Commentary
Management is currently focused on executing strategic shifts to strengthen the company's presence in the global life sciences supply chain. The firm prioritises high-growth chemical segments to drive business expansion.
Growth Outlook
Growth is expected to be driven by the company's focus on high-growth chemical segments and the development of niche molecules. Strategic collaborations are being utilised to enhance manufacturing capabilities and market reach.
Key Risks
- Regulatory Compliance. The company faces stringent environmental and safety regulations inherent to the chemical manufacturing industry.
- Raw Material Price Volatility. Fluctuations in the cost of chemical feedstocks can significantly impact profit margins.
- Market Competition. The specialty chemicals sector is highly competitive, requiring continuous R&D investment to maintain product differentiation.
- Export Dependency. As an exporter, the company is exposed to geopolitical risks and currency fluctuations affecting international trade.
Start your research today
Unlock AI insights, financials, peers and live data on Eiko Lifescience and 5,000+ companies — free.
Peers · Specialty Chemicals
| Company | Mkt Cap | P/E | EV/EBITDA | Rev Gr YoY | EBITDA Mgn | ROE | ROCE | 1Y Return |
|---|---|---|---|---|---|---|---|---|
Eiko LifescienceEIKO | ₹71 Cr | — | — | — | 8.0% | — | — | -8.1% |
Black Rose IndusBLACKROSE | ₹586 Cr | 19.65 | 13.25 | -0.2% | 12.5% | 17.8% | 23.9% | +10.3% |
Vipul OrganicsVIPULORG | ₹506 Cr | 55.50 | 28.24 | 16.8% | 10.4% | 9.0% | 13.0% | +26.1% |
Plastiblends India LimitedPLASTIBLEN | ₹487 Cr | 11.78 | 6.76 | 5.5% | 9.2% | 9.7% | 12.8% | +4.3% |
Agastya Energy and Infrastructure LimitedSANGINITA | ₹455 Cr | -19.81 | -83.28 | -23.2% | -3.2% | -18.0% | -14.1% | +581.9% |
Aarti SurfactantAARTISURF | ₹449 Cr | 22.93 | 9.64 | 25.2% | 6.1% | 7.7% | 12.4% | +7.3% |
As of Mar 2026
Financials
Eiko Lifescience
BSE: EIKO · Specialty Chemicals
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Unlock Eiko Lifescience's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Eiko Lifescience Limited is an Indian specialty chemicals company focused on the manufacturing and export of pharmaceutical intermediates, additives, and functional ingredients. The company serves diverse sectors including pharmaceuticals, agrochemicals, and personal care through a research-driven approach.
Business Model
The company generates revenue by manufacturing and supplying niche chemical molecules and intermediates to global and domestic clients. It leverages strategic collaborations and R&D capabilities to maintain its position within the life sciences supply chain.
Management Commentary
Management is currently focused on executing strategic shifts to strengthen the company's presence in the global life sciences supply chain. The firm prioritises high-growth chemical segments to drive business expansion.
Growth Outlook
Growth is expected to be driven by the company's focus on high-growth chemical segments and the development of niche molecules. Strategic collaborations are being utilised to enhance manufacturing capabilities and market reach.
Key Risks
- Regulatory Compliance. The company faces stringent environmental and safety regulations inherent to the chemical manufacturing industry.
- Raw Material Price Volatility. Fluctuations in the cost of chemical feedstocks can significantly impact profit margins.
- Market Competition. The specialty chemicals sector is highly competitive, requiring continuous R&D investment to maintain product differentiation.
- Export Dependency. As an exporter, the company is exposed to geopolitical risks and currency fluctuations affecting international trade.
Start your research today
Unlock AI insights, financials, peers and live data on Eiko Lifescience and 5,000+ companies — free.
Peers · Specialty Chemicals
As of Mar 2026